AI MARKET SCANNING

Absci Corporation

📅 Next Catalyst: Nov 12, 2026 (☀️ Open) 🏛️ NASDAQ 📁 Healthcare 🏭 Biotechnology
AVG HISTORICAL GAP -2.07%
MAX GAP RECORD +21.96%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $ABSI
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 12, 2026 Earnings Release 2026-11-12 (BEFORE OPEN (07:00)) 🔮 UPCOMING 🔒
Aug 11, 2026 Earnings Release 2026-08-11 (AFTER CLOSE)
-4.14%
May 07, 2026 Earnings Release 2026-05-07 (AFTER CLOSE)
-12.35%
Nov 12, 2025 Earnings Release 2025-11-12 (AFTER CLOSE)
-12.35%
Aug 12, 2025 Earnings Release 2025-08-12 (AFTER CLOSE)
-4.55%
May 13, 2025 Earnings Release 2025-05-13 (AFTER CLOSE)
+21.96%
Mar 18, 2025 Earnings Release 2025-03-18 (AFTER CLOSE)
-2.60%
Nov 12, 2024 Earnings Release 2024-11-12 (BEFORE OPEN)
-4.21%

VOLATILITY & GAP BIAS

AVG GAP MOVE 6.8%
Bullish Gaps (3)
Bearish Gaps (9)
Neutral / Flat (1)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $ABSI

EXECUTIONS2 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-08-07 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 1247m +7.11%
••••-••-•• 🔒 LOCKED ••• x• $•••.•• → $•••.•• ••m +••.••%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States. Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; ABS-201, an anti-prolactin receptor (PRLR) antibody, which is phase 1/2a clinical trial for treating androgenic alopecia;…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗